But in our study, we found that miR-19a decreased the level of phosphorylation of Akt in NSCLC cells under gefitinib treated (Fig. 4E, Fig. S3E).The difference above may be attributed to the treatment of gefitinib and different target genes. Here, AKT1 is linked to non-small cell lung carcinoma.